SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-22-057173
Filing Date
2022-09-20
Accepted
2022-09-20 09:10:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 ea166036-posam_inmedpharma.htm POS AM 116486
  Complete submission text file 0001213900-22-057173.txt   117466
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: POS AM | Act: 33 | File No.: 333-253925 | Film No.: 221252164
SIC: 2834 Pharmaceutical Preparations